U nas zapłacisz kartą
Vita C Infusion Mikrodermabrazja - Twoje Klucze do Promiennej Skóry
Intravenous High-Dose Vitamin C in Cancer Therapy
Lewis Cantley received his Ph.D. from Cornell University and did his post-doctoral work at Harvard University. He was formerly a professor in the Departments of Systems Biology and Medicine at Harvard Medical School in Boston. He is current the Meyer Director and Professor of Cancer Biology at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine in New York City. Jihye Yun received her Ph.D. from Johns Hopkins University, School of Medicine under the mentorship of Bert Vogelstein and did her post-doctoral work with Lewis Cantley at Weill Cornell Medicine. She is currently an Assistant Professor and a CPRIT scholar at Baylor College of Medicine in Houston.
The discovery and isolation of vitamin C was one of the most important advances in improving human nutrition. Scurvy, a severe vitamin C deficiency disease characterized by weakness, lethargy, easy bruising and bleeding, was particularly problematic for sailors on long voyages during the 16th century, where access to fresh fruits and vegetables was limited. In fact, scurvy was the leading cause of naval deaths between the 16th and 18th centuries, killing more sailors than all battles, storms and other diseases combined. It wasn’t until 1747 that Scottish naval physician James Lind demonstrated that consuming oranges and lemons cured and prevented scurvy. However, it took scientists nearly two more centuries to identify the nature of the curative substance contained in citrus fruits, now commonly known as vitamin C. The search for this elusive substance ended in 1932 when Albert Szent-Gyorgyi, a Hungarian biochemist, isolated and identified a 6-carbon carbohydrate, hexuronic acid, as the anti-scurvy factor. Shortly thereafter, Szent-Gyorgyi renamed it “a-scorbic acid”, a reference to its anti-scorbutic properties, and later went on to receive the Nobel Prize in Physiology and Medicine in 1937 for his discoveries.
Ingredients overview
Key Ingredients
Show all ingredients by function
Other Ingredients
| Ingredient name | what-it-does | irr. , com. | ID-Rating |
|---|---|---|---|
| Aqua | solvent | ||
| Alumina | viscosity controlling, abrasive/scrub | ||
| Caprylic/Capric Triglyceride | emollient | ||
| Vitis Vinifera Seed Oil | antioxidant, emollient | goodie | |
| Glycerin | skin-identical ingredient, moisturizer/humectant | 0 , 0 | superstar |
| Sodium Polyacrylate | viscosity controlling | ||
| Urea | skin-identical ingredient, moisturizer/humectant | goodie | |
| Myrciaria Dubia Fruit Extract | |||
| Hippophae Rhamnoides Oil | antioxidant, emollient | goodie | |
| Helianthus Annuus Seed Oil | emollient | 0 , 0 | goodie |
| Rosmarinus Officinalis Leaf Extract | antioxidant, soothing, antimicrobial/antibacterial | goodie | |
| Glycine Soja Oil | emollient, perfuming | 0 , 3 | goodie |
| Sodium Hyaluronate | skin-identical ingredient, moisturizer/humectant | 0 , 0 | goodie |
| Panthenol | soothing, moisturizer/humectant | 0 , 0 | goodie |
| Propanediol | solvent, moisturizer/humectant | ||
| Ascorbyl Palmitate | antioxidant | 0 , 2 | icky |
| Tocopherol | antioxidant | 0 - 3 , 0 - 3 | goodie |
| Hydrogenated Vegetable Glycerides Citrate | emollient, emulsifying | ||
| Propylene Glycol | moisturizer/humectant, solvent | 0 , 0 | |
| Lecithin | emollient, emulsifying | goodie | |
| Caprylyl Glycol | moisturizer/humectant, emollient | ||
| Beta-Sitosterol | |||
| Squalene | skin-identical ingredient, antioxidant, emollient | goodie | |
| Phenoxyethanol | preservative | ||
| Lactic Acid | exfoliant, moisturizer/humectant, buffering | superstar | |
| Disodium EDTA | chelating | ||
| Citrus Limon Peel Oil | perfuming | icky | |
| Parfum | perfuming | icky | |
| Limonene | perfuming, solvent | icky | |
| Linalool | perfuming | icky | |
| Hexyl Cinnamal | perfuming | icky | |
| Citral | perfuming | icky | |
| Geraniol | perfuming | icky |
References
[1] Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study . Lancet 2020, 395 :1054–62. [PMC free article] [PubMed] [Google Scholar]
[2] Baladia E, Pizarro AB, Ortiz-Muoz L, et al.. Vitamin C for COVID-19: a living systematic review . Medwave 2020, 20 :e7978–17978. [PubMed] [Google Scholar]
[3] Zaki T, Budnar M, Kalezi A, et al.. Vitamin C biochemistry: From scurvy to COVID-19 treatment . Hrana i Ishrana 2020, 61 :59–70. [Google Scholar]
[4] Ma Jianchun, Lai Sha, Yang Zemin, et al.. Implications of high dose vitamin C for the treatment of COVID-19 . J Guangdong Pharmaceut Univ 2020, 36 :174–7. [Google Scholar]
[5] Kim H, Jang M, Kim Y, et al.. Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection . J Pharmacy Pharmacol 2016, 68 :406–20. [PubMed] [Google Scholar]
[6] Liu F, Zhu Y, Zhang J, et al.. Intravenous high-dose vitamin C for the treatment of severe COVID-19: Study protocol for a multicentre randomised controlled trial . BMJ Open 2020, 10 :e039519. [PMC free article] [PubMed] [Google Scholar]
[8] Smet DD, Smet KD, Herroelen P, et al.. Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality . Am J Clin Pathol 2021, 155 :381–8. [PMC free article] [PubMed] [Google Scholar]
[9] Shamseer L, Moher D, Clarke M, et al.. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation . BMJ 2015, 350 :g7647. [PubMed] [Google Scholar]
[11] Thorlund K, Wetterslev J, Awad T, et al.. Comparison of statistical inferences from the DerSimonian-Laird and alternative random-effects model meta-analyses - an empirical assessment of 920 Cochrane primary outcome meta-analyses . Res Synth Methods 2011, 2 :238–53. [PubMed] [Google Scholar]